Fig. 4

Evaluation of BARD1 gene expression level in relation with clinicopathological characters in breast cancer patients: A BARD1 mRNA expression level according to histological Scarff Bloom & Richardson grade status of breast cancer, SRB1(544), SRB2(1699), SRB3(1374). B BARD1 mRNA expression level according to lymph node (N) status in breast tuomrs, N- (2415) and N+ (1646). C BARD1 mRNA expression level in correlation with clinical stages, I (177), II (584), III (225), IV (27). D BARD1 mRNA expression level in association with ER/PR expression, ER+/PR+ (3446), ER+/PR- (325), ER−/PR+ (46), ER−/PR- (502). E BARD1 mRNA expression level according to HER2 enriched, HER2- (3582) and HER2+ (651). F BARD1 mRNA expression level according to TP53 mutation status, wild type (699) and mutated (328). G BARD1 mRNA expression level in non-basal & non-TNBC (3690) in comparison to basal & TNBC tumor tissues (267). Source: Database of The Breast Cancer Gene-Expression Miner v4.8 (bcGenExMiner v4.8) (http://bcgenex.ico.unicancer.fr/BC-GEM/GEM-Accueil.php?js=1) [61]